ATE400812T1 - Zusammensetzungen und verfahren für verstärkte apoptose - Google Patents
Zusammensetzungen und verfahren für verstärkte apoptoseInfo
- Publication number
- ATE400812T1 ATE400812T1 AT03815888T AT03815888T ATE400812T1 AT E400812 T1 ATE400812 T1 AT E400812T1 AT 03815888 T AT03815888 T AT 03815888T AT 03815888 T AT03815888 T AT 03815888T AT E400812 T1 ATE400812 T1 AT E400812T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- methods
- enhanced apoptosis
- apoptosis
- matter
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/003799 WO2004072641A1 (en) | 2003-02-07 | 2003-02-07 | Compositions and methods for enhancing apoptosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE400812T1 true ATE400812T1 (de) | 2008-07-15 |
Family
ID=32867400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03815888T ATE400812T1 (de) | 2003-02-07 | 2003-02-07 | Zusammensetzungen und verfahren für verstärkte apoptose |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1590666B1 (de) |
JP (1) | JP4315249B2 (de) |
AT (1) | ATE400812T1 (de) |
AU (3) | AU2003216203A1 (de) |
CA (1) | CA2514316A1 (de) |
DE (1) | DE60322120D1 (de) |
WO (1) | WO2004072641A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2558615C (en) | 2004-03-23 | 2013-10-29 | Genentech, Inc. | Azabicyclo-octane inhibitors of iap |
CN101035802A (zh) | 2004-07-02 | 2007-09-12 | 健泰科生物技术公司 | Iap抑制剂 |
EA019420B1 (ru) | 2004-12-20 | 2014-03-31 | Дженентех, Инк. | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) |
BRPI0611922A2 (pt) * | 2005-06-08 | 2010-10-05 | Novartis Ag | compostos orgánicos |
CN101374829A (zh) | 2005-12-19 | 2009-02-25 | 健泰科生物技术公司 | Iap的抑制剂 |
WO2007101347A1 (en) * | 2006-03-07 | 2007-09-13 | Aegera Therapeutics Inc. | Bir domain binding compounds |
MY159563A (en) | 2006-05-16 | 2017-01-13 | Pharmascience Inc | Iap bir domain binding compounds |
AU2007337104A1 (en) | 2006-12-19 | 2008-07-03 | Genentech, Inc. | Imidazopyridine inhibitors of IAP |
AR066348A1 (es) | 2007-04-30 | 2009-08-12 | Genentech Inc | Inhibidores de las iap |
NZ590550A (en) | 2008-08-02 | 2013-05-31 | Genentech Inc | Inhibitors of Apoptosis (IAP) for treating cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6472172B1 (en) * | 1998-07-31 | 2002-10-29 | Schering Aktiengesellschaft | DNA encoding a novel human inhibitor-of-apoptosis protein |
IT1318691B1 (it) * | 2000-09-12 | 2003-08-27 | Consiglio Nazionale Ricerche | Varianti di proteine allergeniche del gruppo 2 di dermatophagoides. |
WO2002026775A2 (en) * | 2000-09-29 | 2002-04-04 | Trustees Of Princeton University | Compositions and methods for regulating apoptosis |
MXPA03010762A (es) * | 2001-05-31 | 2005-03-07 | Univ Princeton | Peptidos enlazantes de iap y ensayos para identificar los compuestos que enlazan el iap. |
WO2003040172A2 (en) * | 2001-11-09 | 2003-05-15 | Aegera Therapeutics, Inc. | Methods and reagents for peptide-bir interaction screens |
-
2003
- 2003-02-07 JP JP2004568261A patent/JP4315249B2/ja not_active Expired - Fee Related
- 2003-02-07 WO PCT/US2003/003799 patent/WO2004072641A1/en active Application Filing
- 2003-02-07 EP EP03815888A patent/EP1590666B1/de not_active Expired - Lifetime
- 2003-02-07 DE DE60322120T patent/DE60322120D1/de not_active Expired - Lifetime
- 2003-02-07 CA CA002514316A patent/CA2514316A1/en not_active Abandoned
- 2003-02-07 AT AT03815888T patent/ATE400812T1/de not_active IP Right Cessation
- 2003-02-07 AU AU2003216203A patent/AU2003216203A1/en not_active Abandoned
-
2008
- 2008-06-23 AU AU2008202756A patent/AU2008202756A1/en not_active Abandoned
-
2011
- 2011-02-01 AU AU2011200426A patent/AU2011200426B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2003216203A1 (en) | 2004-09-06 |
AU2011200426B2 (en) | 2014-03-06 |
AU2011200426A1 (en) | 2011-02-24 |
DE60322120D1 (de) | 2008-08-21 |
EP1590666B1 (de) | 2008-07-09 |
AU2008202756A1 (en) | 2008-07-17 |
WO2004072641A1 (en) | 2004-08-26 |
CA2514316A1 (en) | 2004-08-26 |
JP2006514963A (ja) | 2006-05-18 |
EP1590666A4 (de) | 2006-07-26 |
EP1590666A1 (de) | 2005-11-02 |
JP4315249B2 (ja) | 2009-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE464323T1 (de) | Zusammensetzungen und verfahren für die tumor- diagnose und behandlung | |
SG155947A1 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
MY150531A (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
MXPA04002593A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. | |
MXPA03011985A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
MXPA03001645A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
ATE527251T1 (de) | Bicyclische derivate als modulatoren von ionenkanälen | |
ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
NO20062860L (no) | Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet | |
MA28909B1 (fr) | Quinazolines utiles en tant que modulateurs de canaux ioniques | |
NO20092637L (no) | Fremgangsmater for behandling | |
WO2005049075A3 (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
WO2005063299A3 (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
WO2005049853A3 (en) | Compositions and methods for screening pro-apoptotic compounds | |
ATE494296T1 (de) | Zusammensetzungen und verfahren für die tumordiagnose und behandlung | |
CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
ATE400812T1 (de) | Zusammensetzungen und verfahren für verstärkte apoptose | |
WO2006014335A3 (en) | Compositions and methods for treatment of non-hodgkin’s lymphoma | |
MXPA03001643A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
DE60329326D1 (de) | Tace inhibitoren | |
WO2004096124A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003243381A8 (en) | Variants of antithrombin iii | |
MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
MXPA03001644A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |